GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Other Gross PPE

Oncodesign Precision Medicine (XPAR:ALOPM) Other Gross PPE : €1.11 Mil (As of Jun. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Other Gross PPE?

Oncodesign Precision Medicine's Other Gross PPE for the quarter that ended in Jun. 2022 was €1.11 Mil.

Oncodesign Precision Medicine's quarterly Other Gross PPE increased from Dec. 2020 (€0.39 Mil) to Dec. 2021 (€1.03 Mil) and increased from Dec. 2021 (€1.03 Mil) to Jun. 2022 (€1.11 Mil).

Oncodesign Precision Medicine's annual Other Gross PPE increased from . 20 (€0.00 Mil) to Dec. 2020 (€0.39 Mil) and increased from Dec. 2020 (€0.39 Mil) to Dec. 2021 (€1.03 Mil).


Oncodesign Precision Medicine Other Gross PPE Historical Data

The historical data trend for Oncodesign Precision Medicine's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Other Gross PPE Chart

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21
Other Gross PPE
0.39 1.03

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22
Other Gross PPE 0.39 1.03 1.11

Oncodesign Precision Medicine Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines